Co-led by Tal Band, Dovev Apel, and Ran Vogel, the team at S. Horowitz & Co exhibits deep expertise in the full spectrum of issues concerning product liability cases, IP, and sector specific regulation. The team is noted for handling the patent aspects of corporate transactions, particularly in relation to the financing of innovation focused companies and patent licences. Band is well-versed in the full range of IP issues, including patent, trade mark, and copyright disputes, regularly appearing before the Israeli Patents and Trademarks Office. Apel is particularly adept at handling regulatory issues concerning medical devices, e-health, and pharma, with emphasis on class actions and cases concerning the advertising and distribution of medical products, areas in which Yair Ziv also has a great deal of expertise.
Key clients
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Masimo International SARL
- Clever Leaves Holdings, Inc.
- Sun Pharmaceutical Industries Ltd.
- Taro Pharmaceutical Industries Ltd.
- Natera Inc
- The Chemical, Pharmaceutical and Environmental Society of the Manufacturer’s Association of Israel
- Maccabi Healthcare Services
- Procter & Gamble Israel Ltd.
- Dexcel Ltd. and Dexcel Pharma Technologies Ltd.
- Novocure Inc.
- Calsado Ltd. (Clasado Biosciences)
- Hadassah Medical Organization
- Allergan Inc.
- Aleph Farm Ltd.
- A.M.I. Medical Technologies Ltd.
- Nevia Bio Ltd. (Gina-Life Diagnostics)
- Femi Premium Ltd
- Forever Living Products (Israel) Ltd.
- Seegnal e-health Ltd
- Kurt Wolff GmbH & Co. KG
- Medial Research Ltd
- Yeda Research and Development Ltd.
- The Institute for Skin Research
- Applied Medical Resources Corporation
- Zimmer Biomet
- Takeda Pharmaceutical Company
- Provention Bio, Inc.
- Galmed International Ltd.
- Hadasit Medical Research Services and Development Ltd.
- American Orthodontics
- Simplivia Healthcare Ltd.
- Solomon, Levine, and Elstein Ltd.
- Tel Aviv University
- Euromar Ltd.
- Amgen Inc.
- Rhenium Research Laboratory Equipment Ltd.
- Alpa Cosmetics
- K.I. Research Institute (R.A.)
- BizTec Entrepreneurship Program
Work highlights
- Represented Teva Pharmaceutical Industries Ltd. in a motion for preliminary injunction submitted by Novartis AG, regarding Teva's important launch and subsequent commercial activity in Europe with regards to Fingolimod.
- Representing Sanofi Aventis SA in a complex motion for certification of a class action suit in the amount of USD 1.5bn, regarding the scope of the information contained in the Consumer Medicine leaflet and summary of product characteristics leaflet.
- Representing Dexcel and Dexcel Pharma in motions for certification of class actions in connection with an alleged defect in a pharmaceutical preparation, totaling approx. NIS 503m.
Lawyers
Practice head
The lawyer(s) leading their teams.
Tal Band, Dovev Apel, Ran Vogel